First-ever validated criteria for symptomatic calcium pyrophosphate deposition disease. Entry, exclusion, and sufficient criteria apply before the scored domains. Score >56 classifies as CPPD.
Age when joint pain, swelling, or tenderness first began. CPPD is strongly associated with older age; onset after 60 is a key positive feature.
A typical episode is defined as an episode with acute onset or acute worsening of joint pain with swelling and/or warmth that resolves regardless of treatment. Persistent inflammatory arthritis means ongoing joint swelling with pain and/or warmth in one or more joints. Select the highest-weighted item that applies.
Location of inflammatory episode(s) in peripheral joints. The knee and wrist are the most characteristic sites for CPPD. First MTP involvement is atypical for CPPD (it suggests gout) and is scored negatively. Select only the highest-weighted item that applies.
Specific metabolic conditions that predispose to CPP crystal deposition through various mechanisms. These include hereditary hemochromatosis, primary hyperparathyroidism, hypomagnesemia, Gitelman syndrome, hypophosphatasia, or a familial history of CPPD disease (first-degree relative).
From a symptomatic joint or bursa. Should be performed by a trained observer using compensated polarized light microscopy. CPP crystals have positive birefringence and may be weakly or non-birefringent - regular light microscopy may be more sensitive. If not performed, score as 0.
Osteoarthritis at specific hand/wrist joints on imaging (K/L score ≥2). These particular joint patterns are characteristic of CPPD-associated OA. Score the highest-weighted finding.
Linear or punctate calcification of fibrocartilage or hyaline cartilage in a symptomatic peripheral joint. Do not score calcification of the synovial membrane, joint capsule, or tendons. Advanced imaging (US, CT, DECT) is more sensitive than conventional X-ray.
Total count of peripheral joints (regardless of whether they are currently symptomatic) showing evidence of CPP crystal deposition on any imaging modality (CR, US, CT, or DECT). This is the single most influential domain - bilateral imaging significantly increases the potential score.
| Domain | Options | Score |
|---|---|---|
| A. Age at onset | ≤60 / >60 years | 0, +4 |
| B. Time-course | None / persistent / 1 episode / >1 episode | 0, +9, +12, +16 |
| C. Sites | 1st MTP / none / other / wrist / knee | -6, 0, +5, +8, +9 |
| D. Metabolic diseases | None / present | 0, +6 |
| E. Synovial fluid | Not done / negative x1 / negative x≥2 | 0, -1, -7 |
| F. OA hand/wrist | None / bilateral radiocarpal / STT+MCP pattern | 0, +2, +7 |
| G. Imaging in symptomatic joint | Positive / CR only negative / advanced negative | +16, 0, -4 |
| H. Number of joints with CPPD | 0 / 1 / 2-3 / ≥4 | 0, +16, +23, +25 |
| Classification threshold | >56 | |